L Blumgart
Overview
Explore the profile of L Blumgart including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
173
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Robson P, Heffernan N, Gonen M, Thornton R, Brody L, Holmes R, et al.
Ann Surg Oncol
. 2010 Apr;
17(9):2303-11.
PMID: 20358300
Background: Percutaneous biliary drainage (PBD) is used to relieve malignant bile duct obstruction (MBO) when endoscopic drainage is not feasible. Little is known about the effects of PBD on the...
2.
Kemeny N, Jarnagin W, Gonen M, Stockman J, Blumgart L, Sperber D, et al.
J Clin Oncol
. 2003 Aug;
21(17):3303-9.
PMID: 12947066
Purpose: Patients who undergo resection of liver metastases from colorectal cancer have an average 2-year survival of 65%. With hepatic arterial infusion (HAI) plus systemic fluorouracil and leucovorin, 2-year survival...
3.
Tihan T, Blumgart L, Klimstra D
Hum Pathol
. 1998 Mar;
29(2):196-200.
PMID: 9490284
Cholangiocarcinomas may be extrahepatic or intrahepatic; the latter are further divided into hilar and peripheral types. Peripheral cholangiocarcinomas often resemble adenocarcinomas arising in other organs. Although clear cell changes may...
4.
Kronawitter U, Kemeny N, Blumgart L
Cancer
. 1997 Aug;
80(4):656-60.
PMID: 9264347
Background: Neutropenic enterocolitis is observed in approximately 25% of patients with acute leukemia, but has been reported rarely in patients with solid tumors. If treatment is not initiated promptly, the...
5.
Vauthey J, Klimstra D, Franceschi D, Tao Y, Fortner J, Blumgart L, et al.
Am J Surg
. 1995 Jan;
169(1):28-34; discussion 34-5.
PMID: 7817995
Background: Experience with hepatocellular carcinoma (HCC) is limited in the West and factors affecting outcome after resection are not clearly defined. Methods: Between 1970 and 1992, 106 patients (including 74...
6.
Borner M, Castiglione M, Triller J, Baer H, Soucek M, Blumgart L, et al.
Ann Oncol
. 1992 Feb;
3(2):113-5.
PMID: 1606081
The feasibility of one whole liver chemoembolization (CE) procedure with Angiostat, a vasoocclusive collagen, mitomycin, doxorubicin, and cisplatin was evaluated in eight patients with unresectable colorectal carcinoma metastatic to the...
7.
Soreide O, Czerniak A, Bradpiece H, Bloom S, Blumgart L
Am J Surg
. 1986 Apr;
151(4):518-23.
PMID: 2421594
Clinical and laboratory data for nine patients with hepatocellular fibrolamellar carcinoma treated at our institution have been summarized with emphasis on the relevance of plasma neurotensin levels as a tumor...
8.
Citrin D, Bessent R, Tuohy J, Elms S, McGinlay E, Greig W, et al.
Br J Radiol
. 1975 Feb;
48(566):118-21.
PMID: 164970
No abstract available.